Sign In
Buy LNSR
$5.66
-0.0800 (-1.39%)
At Close: Jun 22, 2026
LENSAR to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023
08:00am, Wednesday, 02'nd Aug 2023
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the tr
LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups
07:00am, Monday, 24'th Jul 2023
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the tr
LENSAR to Report First Quarter 2023 Financial Results on Monday, May 15, 2023
08:00am, Wednesday, 10'th May 2023
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the tr
LENSAR, Inc. (LNSR) Q3 2022 Earnings Call Transcript
11:29am, Saturday, 12'th Nov 2022
LENSAR, Inc. (NASDAQ:LNSR ) Q3 2022 Results Conference Call November 9, 2022 8:30 AM ET Company Participants Lee Roth - Burns McClellan Nick Curtis - Chief Executive Officer Tom Staab - Chief Financia
LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update
07:00am, Wednesday, 09'th Nov 2022
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the tr
LENSAR, Inc. (LNSR) CEO Nicholas Curtis on Q2 2022 Results - Earnings Call Transcript
10:59am, Monday, 08'th Aug 2022
LENSAR, Inc. (NASDAQ:LNSR ) Q2 2022 Earnings Conference Call August 8, 2022 8:30 AM ET Company Participants Lee Roth - Burns McClellan Nicholas Curtis - Chief Executive Officer Thomas Staab - Chief Fi
LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update
07:00am, Monday, 08'th Aug 2022
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the tr
LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022
08:00am, Monday, 01'st Aug 2022
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the tr
Why Lensar Shares Are Trading Higher Today
09:14am, Monday, 13'th Jun 2022
The FDA granted 510(k) clearance to Lensar Inc's (NASDAQ: LNSR) next-generation ALLY Adaptive Cataract Treatment System (ALLY System). ALLY is the first FDA-cleared platform to enable cataract sur
LENSAR, Inc. (LNSR) CEO Nick Curtis on Q1 2022 Results - Earnings Call Transcript
10:57am, Monday, 09'th May 2022
LENSAR, Inc. (NASDAQ:LNSR ) Q1 2022 Earnings Conference Call May 9, 2022 8:30 AM ET Company Participants Cameron Radinovic - Burns McClellan Nick Curtis - Chief Executive Officer Tom Staab - Chief Fin
LENSAR, Inc. (LNSR) Reports Q1 Loss, Tops Revenue Estimates
09:51am, Monday, 09'th May 2022
LENSAR, Inc. (LNSR) delivered earnings and revenue surprises of 23.86% and 4.80%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Thermo Fisher Scientific (TMO) Surpasses Q1 Earnings and Revenue Estimates
11:15am, Thursday, 28'th Apr 2022 Zacks Investment Research
Thermo Fisher (TMO) delivered earnings and revenue surprises of 17.50% and 11.17%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: LENSAR, Inc. (LNSR) Q1 Earnings Expected to Decline
07:03pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
LENSAR, Inc. (LNSR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: LENSAR, Inc. (LNSR) Q1 Earnings Expected to Decline
04:49pm, Wednesday, 27'th Apr 2022
LENSAR, Inc. (LNSR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Edwards Lifesciences (EW) Beats Q1 Earnings and Revenue Estimates
09:35pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
Edwards Lifesciences (EW) delivered earnings and revenue surprises of 3.45% and 2.44%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
